Independent health and science journalist Benjamin Ryan's Substack focuses on pediatric gender medicine in particular.
Live Last read · last published · next check
In 2012, the British TV show Surprise Surprise awarded Arday after hearing from his then-partner Debbie McKenzie that he couldn't read until age 16 (he's long said 18) and had raised nearly £250,000.
You can't make this up: The title of the apparent fabulist's memoir is the same as an episode of the TV show, and the book includes quotes from prophets that are similar to dialogue from the show.
I spoke with the New York Times Opinion columnist and Columbia linguist, who is a critic of affirmative action, about the Greek-tragedian downfall of now-former Cambridge professor Jason Arday.
In a previously unreported recording I obtained of a speech the besieged professor gave a year ago, Arday provided a litany of claims about threats he’s received—which to date remain uncorroborated.
The Cambridge star professor now says his £5.5 million charity total was the work of a 100-person syndicate. I found every version of the story since 2010, down to his £6,285 JustGiving page.
At the 2022 WPATH conference, trans providers dismissed the gender binary a "project of colonialism" and looked witheringly upon psych assessments for youths seeking gender-transition interventions.
I went on Alex Berenson's podcast for a Substack live to discuss my recent essay for him about the political catastrophe that the transgender movement has faced.
Over a decade, the study of gender-transition interventions for youths received some $10 million in taxpayer funds. But it has not produced papers on documenting longer than two years of follow-up.
Dr. Madeline Deutsch led the US branch of the World Professional Association for Transgender Health through some tumultuous times, in part by squelching public expressions of dissent.
Transfeminine jurist Florence Ashley calls barriers to youth gender care illegitimate by default. Her published work has spent years building that case.
Canadian pediatrician Dr. Natasha Johnson's appointment to lead the society has alarmed three families I spoke with after she fast tracked their adolescent children for gender-transition drugs.
The study’s leaders have announced it will proceed after all. But absent a planned 2nd phase to study cross-sex hormones, the trial is likely to amount to not much more than a $14 million cash sink.
Make it make sense! A 2022 WPATH conference session never acknowledged this glaring paradox as speakers preached about providing Native Americans with gender-transition treatment and surgeries.
This rate, from a study of data about insured adolescents in Oregon, represents an average over this period. Given swift increases in hormone uptake over time, the rate was likely much higher by 2023.
A new study based on nationalized Finnish health data found that gender-transition treatment was not associated with a tempered need for eating-disorder treatment.
In a 2022 conference presentation, Dr. Natasha Johnson said parental concerns were not tied to 2-year treatment regret among their kids, and thus "should not be prioritized over youths' experiences."
At a 2022 conference panel, advocates set out to expose "junk science" in laws banning gender-transition treatments for minors, only to rebut them with multiple false or non-evidence-based claims.
In a 2021 plenary address, the lead investigator of the $10 million Trans Youth Care Study previewed one-year results and promised five-year data was coming. It still hasn't come.
At a 2022 conference, an author of the new transgender-care guidelines urged clinicians to spread responsibility across a team — acknowledging both the absence of long-term evidence and the potential for patient regret.
I obtained a trove of internal communications documenting how Ms. Reed's advocacy led the body that oversees continuing medical education for doctors to void a course that cast doubt on this field.
